Anybody know which institutions hold DUSA? I think alot of the volatity of the market is being caused by institutions dumping stocks at the slightest sign of a stocks weakness. Also I would never invest in a penny stock like HYALF, I don't care what their product is. You want to talk about stock manipulation, trade on the Nasdaq BB or PinkSheets! I believe that it is harder to get drug approval in the US than pratically anywhere else in the world, so what makes HYALF a lock for approval here?
Another thought even if HYALF and Levulan are both approved, which one is the consumer (insurance company) going to pay for? My guess is the one that requires the least amount of treatments.
DUSA has a good product which has been successful in its trials; it will find another partner in the next 6 months and it in the long run will be a winner. The hardest thing for an investor is to stick to their guns when everyone is running for the doors.